Inventor
WARRIER JAYAKUMAR SANKARA
IN19 patents
⚠️ This page may combine multiple inventors who share the name “WARRIER JAYAKUMAR SANKARA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
15 patentsUS9221796B2Dec 29, 2015
Selective NR2B antagonists
BRISTOL MYERS SQUIBB CO5 citations72
US10669272B2Jun 2, 2020
Substituted naphthyridinone compounds useful as T cell activators
BRISTOL MYERS SQUIBB CO4 citations70
US8722670B2May 13, 2014
Selective NR2B antagonists
BRISTOL MYERS SQUIBB CO2 citations62
US10954225B2Mar 23, 2021
Selective NR2B antagonists
BRISTOL MYERS SQUIBB CO0 citations60
US10336761B2Jul 2, 2019
TGFβ receptor antagonist
BRISTOL MYERS SQUIBB CO1 citations60
US11713316B2Aug 1, 2023
Substituted naphthyridinone compounds useful as T cell activators
BRISTOL MYERS SQUIBB CO0 citations59
US10961229B2Mar 30, 2021
Selective NR2B antagonists
BRISTOL MYERS SQUIBB CO0 citations59
US10954238B1Mar 23, 2021
Substituted naphthyridinone compounds useful as T cell activators
BRISTOL MYERS SQUIBB CO0 citations59
US10344020B2Jul 9, 2019
Selective NR2B antagonists
BRISTOL MYERS SQUIBB CO1 citations59
US12492172B2Dec 9, 2025
Substituted quinazolinyl compounds useful as T cell activators
BRISTOL MYERS SQUIBB CO0 citations51
US12454531B2Oct 28, 2025
Substituted piperazine derivatives useful as T cell activators
BRISTOL MYERS SQUIBB CO0 citations51
US11964973B2Apr 23, 2024
Substituted bicyclic compounds useful as T cell activators
BRISTOL MYERS SQUIBB CO0 citations50
US10501451B2Dec 10, 2019
Selective NR2B antagonists
BRISTOL MYERS SQUIBB CO0 citations50
US10961239B2Mar 30, 2021
TGF beta receptor antagonists
BRISTOL MYERS SQUIBB CO0 citations49
US11584747B2Feb 21, 2023
Substituted pyridopyrimidinonyl compounds useful as T cell activators
BRISTOL MYERS SQUIBB CO0 citations48
RIGEL PHARMACEUTICALS INC
4 patentsUS9884868B2Feb 6, 2018
TGF-beta inhibitors
RIGEL PHARMACEUTICALS INC2 citations71
US11352360B2Jun 7, 2022
TGF-beta inhibitors
RIGEL PHARMACEUTICALS INC0 citations60
US10287295B2May 14, 2019
TGF-β inhibitors
RIGEL PHARMACEUTICALS INC0 citations51
US9981944B2May 29, 2018
GDF-8 inhibitors
RIGEL PHARMACEUTICALS INC0 citations41